BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2142432)

  • 1. Influence of T-helper cell specific monoclonal antibody on progressive growth of B-cell lymphomas in SJL/J mice: correlation of acute treatment dosage with tumor dormancy or complete remission in long-term survivors.
    Alisauskas RM; Friedman CA; Ponzio NM
    Cancer Commun; 1990; 2(1):33-43. PubMed ID: 2142432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice.
    Alisauskas RM; Ponzio NM
    Cell Immunol; 1989 Apr; 119(2):286-303. PubMed ID: 2467748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse.
    Lin TZ; Fernandes H; Yauch R; Ponzio NM; Raveche E
    Clin Immunol Immunopathol; 1992 Oct; 65(1):10-22. PubMed ID: 1382908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
    Ohnishi K; Bonavida B
    Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo growth inhibition of Ia+ lymphomas in SJL mice treated with I-As-reactive monoclonal antibody.
    Alisauskas RM; Ponzio NM
    Immunopharmacology; 1986 Aug; 12(1):1-9. PubMed ID: 2428770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 suppressor cell activity and its effect on CD4 helper cell-dependent growth of SJL/J B-cell lymphomas.
    Thrush GR; Butch AW; Lerman SP
    Cell Immunol; 1989 Sep; 122(2):555-62. PubMed ID: 2569938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice.
    Wajchman J; Simmons WJ; Klein A; Koneru M; Ponzio NM
    Leuk Res; 2002 Jun; 26(6):577-90. PubMed ID: 12007506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth.
    Erianne1 GS; Wajchman2 J; Yauch3 R; Tsiagbe VK; Kim BS; Ponzio NM
    Leuk Res; 2000 Aug; 24(8):705-18. PubMed ID: 10936423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine mercury-induced autoimmunity: the role of T-helper cells.
    Hultman P; Johansson U; Dagnaes-Hansen F
    J Autoimmun; 1995 Dec; 8(6):809-23. PubMed ID: 8824708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
    Katz JD; Lebow LT; Bonavida B
    J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressiveness of SJL/J lymphomas correlates with absence of H-2Ds antigens.
    Rosloniec EF; Kuhn MH; Genyea CA; Reed AH; Jennings JJ; Giraldo AA; Beisel KW; Lerman SP
    J Immunol; 1984 Feb; 132(2):945-52. PubMed ID: 6606680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
    Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
    J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
    Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
    Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of reticulum-cell sarcomas in SJL/J mice. I. Proliferative response to tumor cells of T-derived lymphoid cells from normal mice.
    Lerman SP; Chapman JM; Carswell EA; Thorbecke GJ
    Int J Cancer; 1974 Dec; 14(6):808-16. PubMed ID: 4618550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.
    French RR; Chan HT; Tutt AL; Glennie MJ
    Nat Med; 1999 May; 5(5):548-53. PubMed ID: 10229232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice.
    Abramowicz D; Vandervorst P; Bruyns C; Doutrelepont JM; Vandenabeele P; Goldman M
    Eur J Immunol; 1990 Aug; 20(8):1647-53. PubMed ID: 2145162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.